BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 38796970)

  • 1. Survival strategies: How tumor hypoxia microenvironment orchestrates angiogenesis.
    Yang M; Mu Y; Yu X; Gao D; Zhang W; Li Y; Liu J; Sun C; Zhuang J
    Biomed Pharmacother; 2024 Jul; 176():116783. PubMed ID: 38796970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Havoc in harmony: Unravelling the intricacies of angiogenesis orchestrated by the tumor microenvironment.
    Acharya SS; Kundu CN
    Cancer Treat Rev; 2024 Jun; 127():102749. PubMed ID: 38714074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Sabotaging Role of Myeloid Cells in Anti-Angiogenic Therapy: Coordination of Angiogenesis and Immune Suppression by Hypoxia.
    Li C; Liu T; Bazhin AV; Yang Y
    J Cell Physiol; 2017 Sep; 232(9):2312-2322. PubMed ID: 27935039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments.
    Wei X; Chen Y; Jiang X; Peng M; Liu Y; Mo Y; Ren D; Hua Y; Yu B; Zhou Y; Liao Q; Wang H; Xiang B; Zhou M; Li X; Li G; Li Y; Xiong W; Zeng Z
    Mol Cancer; 2021 Jan; 20(1):7. PubMed ID: 33397409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Angiogenic Therapy: Current Challenges and Future Perspectives.
    Lopes-Coelho F; Martins F; Pereira SA; Serpa J
    Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33916438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of anti-angiogenic factors in the pathogenesis of breast cancer: A review of therapeutic potential.
    Ruan L; Zhang S; Chen X; Liang W; Xie Q
    Pathol Res Pract; 2022 Aug; 236():153956. PubMed ID: 35700578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor Hypoxia Regulates Immune Escape/Invasion: Influence on Angiogenesis and Potential Impact of Hypoxic Biomarkers on Cancer Therapies.
    Abou Khouzam R; Brodaczewska K; Filipiak A; Zeinelabdin NA; Buart S; Szczylik C; Kieda C; Chouaib S
    Front Immunol; 2020; 11():613114. PubMed ID: 33552076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
    Gacche RN; Meshram RJ
    Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tanshinone IIA inhibits β-catenin/VEGF-mediated angiogenesis by targeting TGF-β1 in normoxic and HIF-1α in hypoxic microenvironments in human colorectal cancer.
    Sui H; Zhao J; Zhou L; Wen H; Deng W; Li C; Ji Q; Liu X; Feng Y; Chai N; Zhang Q; Cai J; Li Q
    Cancer Lett; 2017 Sep; 403():86-97. PubMed ID: 28602978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting hypoxic tumor microenvironment in pancreatic cancer.
    Tao J; Yang G; Zhou W; Qiu J; Chen G; Luo W; Zhao F; You L; Zheng L; Zhang T; Zhao Y
    J Hematol Oncol; 2021 Jan; 14(1):14. PubMed ID: 33436044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges facing antiangiogenesis therapy: The significant role of hypoxia-inducible factor and MET in development of resistance to anti-vascular endothelial growth factor-targeted therapies.
    Mahdi A; Darvishi B; Majidzadeh-A K; Salehi M; Farahmand L
    J Cell Physiol; 2019 May; 234(5):5655-5663. PubMed ID: 30515806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of tumor angiogenesis by microRNAs: State of the art.
    Goradel NH; Mohammadi N; Haghi-Aminjan H; Farhood B; Negahdari B; Sahebkar A
    J Cell Physiol; 2019 Feb; 234(2):1099-1110. PubMed ID: 30070704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reengineering the Tumor Microenvironment to Alleviate Hypoxia and Overcome Cancer Heterogeneity.
    Martin JD; Fukumura D; Duda DG; Boucher Y; Jain RK
    Cold Spring Harb Perspect Med; 2016 Dec; 6(12):. PubMed ID: 27663981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tumor microenvironment.
    Anderson NM; Simon MC
    Curr Biol; 2020 Aug; 30(16):R921-R925. PubMed ID: 32810447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting endothelial cell metabolism in cancerous microenvironment: a new approach for anti-angiogenic therapy.
    Mohammadi P; Yarani R; Rahimpour A; Ranjbarnejad F; Mendes Lopes de Melo J; Mansouri K
    Drug Metab Rev; 2022 Nov; 54(4):386-400. PubMed ID: 36031813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticle Delivery of MnO
    Chang CC; Dinh TK; Lee YA; Wang FN; Sung YC; Yu PL; Chiu SC; Shih YC; Wu CY; Huang YD; Wang J; Lu TT; Wan D; Chen Y
    ACS Appl Mater Interfaces; 2020 Oct; 12(40):44407-44419. PubMed ID: 32865389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia-Dependent Angiogenesis and Lymphangiogenesis in Cancer.
    Schito L
    Adv Exp Med Biol; 2019; 1136():71-85. PubMed ID: 31201717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential roles of tumor-derived exosomes in angiogenesis.
    Ludwig N; Whiteside TL
    Expert Opin Ther Targets; 2018 May; 22(5):409-417. PubMed ID: 29634426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of microenvironment in tumor angiogenesis.
    Jiang X; Wang J; Deng X; Xiong F; Zhang S; Gong Z; Li X; Cao K; Deng H; He Y; Liao Q; Xiang B; Zhou M; Guo C; Zeng Z; Li G; Li X; Xiong W
    J Exp Clin Cancer Res; 2020 Sep; 39(1):204. PubMed ID: 32993787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiogenesis as a hallmark of solid tumors - clinical perspectives.
    Majidpoor J; Mortezaee K
    Cell Oncol (Dordr); 2021 Aug; 44(4):715-737. PubMed ID: 33835425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.